Berry Plastics Group, Inc. Appoints Scott B. Ullem to the Company's Board of Directors
BusinessWire - Tue Aug 02, 7:30AM CDT
Berry Plastics Group, Inc. (NYSE:BERY), a leading global manufacturer and marketer of innovative consumer packaging and engineered specialty materials, today announced the appointment of Scott B. Ullem to its Board of Directors.
BERY: 40.97 (-0.27), EW: 114.51 (+0.93)
Edwards Lifesciences (EW) Catches Eye: Stock Jumps 5.6%
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:40AM CDT
Edwards Lifesciences Corp. (EW) saw its shares rise almost 6% in the last trading session.
ABMD: 119.18 (+0.27), EW: 114.51 (+0.93)
Upgrade Alert for Edwards Lifesciences (EW)
Comtex SmarTrend(R) - Thu Jul 28, 3:52AM CDT
Edwards Lifesciences (NYSE:EW) was upgraded from Neutral to Buy at BofA/Merrill today. The stock closed yesterday at $114.44 on volume of 5.1 million shares, above average daily volume of 1.9 million. There is potential upside of 51.1% for shares of Edwards Lifesciences based on a current price of $114.44 and an average consensus analyst price target of $172.89. The stock should find initial support at its 50-day moving average (MA) of $96.47 and further support at its 200-day MA of $81.36.
EW: 114.51 (+0.93)
Twitter and Akamai skid; Apple and Edwards climb
AP - Wed Jul 27, 3:35PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:
RHI: 36.48 (-0.01), AKAM: 49.74 (-0.22), GRMN: 55.01 (+0.15), ADI: 62.63 (-0.21), EW: 114.51 (+0.93), LL: 15.29 (+0.09), TWTR: 16.96 (+0.54), AAPL: 105.48 (+1.00)
After Yesterday's Rally of 6.43% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jul 27, 12:04PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $114.01 to a high of $117.46. Yesterday, the shares gained 6.4%, which took the trading range above the 3-day high of $108.38 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 114.51 (+0.93)
Edwards Lifesciences (EW) Tops Q2 Earnings, '16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 11:39AM CDT
Edwards Lifesciences (EW) ended the second quarter on an encouraging note, with its financial numbers squarely beating the Zacks Consensus Estimate.
ABMD: 119.18 (+0.27), MASI: 53.05 (+0.51), CYNO: 52.00 (-0.26), EW: 114.51 (+0.93)
Edwards Receives Approval For SAPIEN 3 Heart Valve In Canada
CNW Group - Wed Jul 27, 10:00AM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Health Canada has approved the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients living with severe, symptomatic aortic stenosis and at high or greater risk for surgical aortic valve replacement.
EW: 114.51 (+0.93)
Edwards Lifesciences (EW) Q2 Earnings: Will It Be a Miss?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 3:56PM CDT
Edwards (EW) has a Zacks Rank #4 (Sell), which along with a negative ESP of -1.43% makes surprise prediction difficult.
AGN: 254.12 (+3.37), EW: 114.51 (+0.93), LH: 139.61 (+0.23), BMY: 75.00 (-0.05)
Zacks Industry Outlook Highlights: Edwards Lifesciences, Medtronic and Johnson & Johnson
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 8:30AM CDT
Zacks Industry Outlook Highlights: Edwards Lifesciences, Medtronic and Johnson & Johnson
JNJ: 124.35 (-0.50), MDT: 87.24 (-0.40), EW: 114.51 (+0.93)
MedTech Industry Stock Outlook - July 2016
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 5:08PM CDT
MedTech Industry Stock Outlook - July 2016
JNJ: 124.35 (-0.50), MDT: 87.24 (-0.40), EW: 114.51 (+0.93)
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 1.53% Gain
Comtex SmarTrend(R) - Wed Jun 08, 2:02PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $100.86 to a high of $103.30. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $102.19 on volume of 568,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 114.51 (+0.93)
How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 119.18 (+0.27), EW: 114.51 (+0.93), ARAY: 5.48 (+0.01), SYK: 115.39 (-0.31)
Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:04AM CDT
Luminex Corp (LMNX) recently announced the receipt of CE-IVD marking for the ARIES Flu A/B & RSV Assay.
MASI: 53.05 (+0.51), EW: 114.51 (+0.93), LMNX: 20.99 (-0.08), CRY: 14.08 (-0.17)
Look for Shares of Edwards Lifesciences to Potentially Rebound after Yesterday's 1.02% Sell Off
Comtex SmarTrend(R) - Tue May 31, 2:23PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $98.64 to a high of $100.66. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $98.97 on volume of 657,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EW: 114.51 (+0.93)
Edwards Lifesciences To Present At Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Tue May 31, 1:51PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the Goldman Sachs 37th Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, California on Tuesday, June 7, 2016.
EW: 114.51 (+0.93)
New Strong Buy Stocks for May 27th
Swarup Gupta - ZACKS - Fri May 27, 8:14AM CDT
New Strong Buy Stocks for May 27th
AMAT: 26.08 (+0.11), RESI: 9.62 (-0.03), EW: 114.51 (+0.93), KT: 15.29 (-0.02), TAST: 11.75 (-0.02)
Edwards Lifesciences: Q1 Strong, TAVR Prospects Bright
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:50AM CDT
Edwards Lifesciences (EW) made a strong start to 2016, with its first-quarter results beating estimates on both the fronts.
BSX: 24.16 (-0.01), SRDX: 27.97 (+0.28), BAX: 48.21 (-0.27), EW: 114.51 (+0.93)
S&P 500 to Celebrate One Year of New High: Top ETFs & Stocks
Sweta Killa - Zacks Investment Research - Fri May 20, 10:27AM CDT
We have highlighted five ETFs and stocks that have generated incredible returns over the past one-year period and have easily crushed the broader market.
REZ: 67.23 (-0.59), FB: 123.39 (+0.30), KBWP: 49.66 (-0.10), EW: 114.51 (+0.93), CPB: 61.19 (-0.12), TSN: 73.38 (-0.10), RHS: 126.86 (-0.36), PEY: 15.55 (-0.03), CVC: 34.87 (-0.01), PSCU: 48.01 (-0.20)
Baxter (BAX) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:22AM CDT
On May 20, Zacks Investment Research raised Baxter International Inc. (BAX) to a Zacks Rank #1 (Strong Buy).
SRDX: 27.97 (+0.28), MASI: 53.05 (+0.51), BAX: 48.21 (-0.27), EW: 114.51 (+0.93)